ArticleBioscience reports2023

The dinitrobenzamide mustard prodrugs, PR-104A and SN27686, for use in a novel MNDEPT cancer prodrug therapy approach.

Patrick Ball et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.